People say to write what you know and Ed Tobias knows about MS. He’s lived with the illness since 1980, when he was 32 years old. Ed’s a retired, award-winning broadcast journalist and his column combines his four decades of MS experiences with news and comments about the latest in the MS community. In addition to writing his column, Ed is one of the patient moderators on the MS News Today Facebook, Twitter, and Instagram sites. He’s also the author of “The Multiple Sclerosis Toolbox: Hints and Tips for Living with M.S.” Ed and his wife split their time between the Washington, D.C. suburbs and Florida’s Gulf Coast, trying to follow the sun.
This is my 823rd column for Multiple Sclerosis News Today. It is also my last. Over the past seven and a half years, I’ve written about multiple sclerosis (MS) fatigue and…
Read more
Higher COVID-19 Risk Tied to 2 MS Therapies, Even With Vaccination According to this study, people being treated with Ocrevus had 3.6 times the risk of a breakthrough COVID-19 infection compared with people…
This news seems disappointing: A Phase 3 clinical trial of nabiximols — which is available under the brand name Sativex in several countries, including Canada and most of Europe — has failed…
OK, I know I look silly wearing this — maybe even scary — but the Father’s Day gift I received from my son and his family is really cool, especially for someone with…
aHSCT, Stem Cell Therapy for RRMS, Troubled by Unknowns, Paper Says This research team says more studies…
Over the many years I’ve lived with multiple sclerosis (MS), I’ve used several medications to treat my…
Vidofludimus Calcium Safely Reduced RRMS Brain Lesions Vidofludimus calcium, also called IMU-838, is an oral therapy designed…
It’s a decision most of us with a chronic illness have to make sooner or later: When do…
Evusheld Boosts Antibodies Against COVID-19 in Vaccinated Patients Research has shown that the COVID-19 vaccines have been…
Will your doctor approve you to buy medical marijuana (MMJ)? Two of mine will and one won’t. The doctor…
FDA Decision on Ublituximab for Relapsing MS Pushed to Year’s End Ublituximab is similar to Ocrevus…
After two days — 16 hours of it spent on the road — and 1,104 miles, I hadn’t…
A few weeks ago, my cane mutinied. I’ve been using canes for about 20 years — first one,…
‘Hidden’ Disabilities Fairly Common at RRMS Diagnosis, Study Finds This headline doesn’t report the full nature of…
It may sound like a joke or a scam, but there’s a nonprofit organization called RIP Medical Debt…
Biogen, MedRhythms Working on Music Therapy for MS Gait Issues This is music to my ears. Sorry,…
The National Institutes of Health (NIH) is joining the search for a vaccine to attack the Epstein-Barr…
Cannabis ‘Highly Effective’ Against MS Symptoms, Some Users Report I would’ve expected many users to report that…
It’s not easy going for a cruise when a scooter and a couple of canes come along for…
PoNS Device for MS-associated Gait Problems Now Available in US One clinical trial showed that MS patients…
What was your first MS symptom? Mine — the one that made me realize something was really…
Get regular updates to your inbox.
